Page last updated: 2024-09-03

norketamine and Neuralgia

norketamine has been researched along with Neuralgia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buvanendran, A; Das, V; Kroin, JS; Moric, M1
Chong, C; Ilett, KF; Jenkins, B; Page-Sharp, M; Schug, SA1
Aarts, L; Dahan, A; Morariu, A; Niesters, M; Swartjes, M1
Dahan, A; Niesters, M1
Breivik, H; Eide, PK; Stubhaug, A; Øye, I1

Reviews

1 review(s) available for norketamine and Neuralgia

ArticleYear
Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain.
    Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:11

    Topics: Animals; Chronic Disease; Disease Models, Animal; Humans; Ketamine; Neuralgia; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate

2012

Trials

1 trial(s) available for norketamine and Neuralgia

ArticleYear
Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study.
    Clinical drug investigation, 2009, Volume: 29, Issue:5

    Topics: Administration, Oral; Administration, Sublingual; Adult; Aged; Analgesics; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Chronic Disease; Cross-Over Studies; Drug Stability; Drug Storage; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Male; Middle Aged; Neuralgia; Temperature

2009

Other Studies

3 other study(ies) available for norketamine and Neuralgia

ArticleYear
Efficacy of the ketamine metabolite (2R,6R)-hydroxynorketamine in mice models of pain.
    Regional anesthesia and pain medicine, 2019, Volume: 44, Issue:1

    Topics: Animals; Disease Models, Animal; Female; Ketamine; Mice; Mice, Inbred C57BL; Neuralgia; Treatment Outcome

2019
Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
    Anesthesiology, 2011, Volume: 115, Issue:1

    Topics: Acute Disease; Analgesics; Animals; Chronic Disease; Cold Temperature; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Foot Injuries; Hyperalgesia; Infrared Rays; Ketamine; Motor Activity; Neuralgia; Pain; Pain Measurement; Physical Stimulation; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior

2011
Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia.
    Pain, 1995, Volume: 61, Issue:2

    Topics: Aged; Female; Herpesviridae Infections; Humans; Infusion Pumps, Implantable; Ketamine; Male; Neuralgia; Prospective Studies; Receptors, N-Methyl-D-Aspartate

1995